The risk for end-stage renal disease in patients with ADPKD is high. What factors increase the risk and how is it best managed? Test yourself.
Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease.
Most children with ADPKD remain asymptomatic, but some manifest early and aggressive disease. Try our 6 questions on the new expert guidance on tricky treatment issues.
Find summaries here of 3 recent studies conducted to shed light on difficult issues in the management of autosomal dominant polycystic kidney disease.
Autosomal dominant polycystic kidney disease is the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more.
Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
The primary care role in detection, management, and reducing the risk of progression of CKD continues to expand. Test yourself here on basics in each category.
Keeping a loop diuretic on board during dialysis could be an effective, low-cost option to help improve patient outcomes, according to a new study.
Authors of the CRIC study found sex-related disparities in chronic kidney disease progression. Scroll through our slideshow to get the highlights.
Renal damage, blood glucose level, family history--which was independently linked to incident T2DM in CKD? Read the study highlights.